BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21178899)

  • 1. Application of cycloaddition reactions to the syntheses of novel boron compounds.
    Zhu Y; Siwei X; Maguire JA; Hosmane NS
    Molecules; 2010 Dec; 15(12):9437-49. PubMed ID: 21178899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlargement of a Modular System-Synthesis and Characterization of an
    Kellert M; Lönnecke P; Riedl B; Koebberling J; Hey-Hawkins E
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31509949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to incorporation of boron in tumor-seeking molecules.
    Sivaev IB; Semioshkin AA; Bregadze VI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology.
    Grams RJ; Santos WL; Scorei IR; Abad-García A; Rosenblum CA; Bita A; Cerecetto H; Viñas C; Soriano-Ursúa MA
    Chem Rev; 2024 Mar; 124(5):2441-2511. PubMed ID: 38382032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of enriched boron nitride nanocrystals: A potential element for biomedical applications.
    Ahmad P; Khandaker MU; Muhammad N; Rehman F; Ullah Z; Khan G; Khan MI; Haq S; Ali H; Khan A; Saeed Y; Irshad MI
    Appl Radiat Isot; 2020 Dec; 166():109404. PubMed ID: 32956924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and use of boronated amino acids for boron neutron capture therapy.
    Kabalka GW; Yao ML
    Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
    Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
    Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment.
    Wang J; Wu W; Jiang X
    Nanomedicine (Lond); 2015; 10(7):1149-63. PubMed ID: 25929571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of drug delivery system to boron neutron capture therapy for cancer.
    Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
    Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron in cancer therapeutics: An overview.
    Kulkarni S; Bhandary D; Singh Y; Monga V; Thareja S
    Pharmacol Ther; 2023 Nov; 251():108548. PubMed ID: 37858628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron Chemistry for Medical Applications.
    Ali F; S Hosmane N; Zhu Y
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
    Renner MW; Miura M; Easson MW; Vicente MG
    Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dodeca(carboranyl)-substituted closomers: toward unimolecular nanoparticles as delivery vehicles for BNCT.
    Thomas J; Hawthorne MF
    Chem Commun (Camb); 2001 Sep; (18):1884-5. PubMed ID: 12240362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy.
    Raddatz S; Marcello M; Kliem HC; Tröster H; Trendelenburg MF; Oeser T; Granzow C; Wiessler M
    Chembiochem; 2004 Apr; 5(4):474-82. PubMed ID: 15185371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
    Takeuchi I; Nomura K; Makino K
    Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
    Yinghuai Z; Hosmane NS
    Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid state, thermal synthesis of site-specific protein-boron cluster conjugates and their physicochemical and biochemical properties.
    Goszczyński TM; Kowalski K; Leśnikowski ZJ; Boratyński J
    Biochim Biophys Acta; 2015 Feb; 1850(2):411-8. PubMed ID: 25445715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boronated thymidine analogues for boron neutron capture therapy.
    Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not boring at all. Boron is the new carbon in the quest for novel drug candidates.
    Hunter P
    EMBO Rep; 2009 Feb; 10(2):125-8. PubMed ID: 19182828
    [No Abstract]   [Full Text] [Related]  

  • 20. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
    Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
    Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.